Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy – final appraisal document

In DRAFT guidance, NICE recommends niraparib for use within the Cancer Drugs Fund as an option for maintenance treatment for advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer after response to first-line platinum-based chemotherapy in adults.

Source:

National Institute for Health and Care Excellence